NasdaqCM - Nasdaq Real Time Price USD

BIOLASE, Inc. (BIOL)

0.1480 +0.0040 (+2.78%)
At close: April 25 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. John R. Beaver President, CEO & Director 377.53k -- 1961
Ms. Jennifer Bright Chief Financial Officer 355.98k -- 1972
Mr. Steven Sandor Chief Operating Officer 336.39k -- 1981
Mr. Michael C. Carroll Corporate Secretary -- -- 1972

BIOLASE, Inc.

27042 Towne Centre Drive
Suite 270
Foothill Ranch, CA 92610-2811
United States
949 361 1200 https://www.biolase.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
157

Description

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Corporate Governance

BIOLASE, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Apr 19, 2024
    POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
    See Full Filing
  • Apr 11, 2024
    POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
    See Full Filing
  • Mar 27, 2024
    S-1/A: Offering Registrations
    See Full Filing
  • Mar 22, 2024
    ARS: Annual Report to Shareholders
    See Full Filing
  • Mar 21, 2024
    10-K: Periodic Financial Reports
    See Full Filing

Upcoming Events

May 09, 2024 - May 13, 2024
BIOLASE, Inc. Earnings Call

Related Tickers

SINT Sintx Technologies, Inc.
0.0366
-5.43%
 
NUWE Nuwellis, Inc.
0.2890
+14.64%
 
MOTS Motus GI Holdings, Inc.
0.0800
+3.90%
 
HSCS Heart Test Laboratories, Inc.
0.0999
-7.41%
 
INBS Intelligent Bio Solutions Inc.
2.4700
-3.89%
 
ZOM Zomedica Corp.
0.1301
-0.08%
 
OPGN OpGen, Inc.
0.5320
-5.51%
 
DYNT Dynatronics Corporation
0.5754
-2.44%
 
INVO INVO Bioscience, Inc.
0.9801
-16.23%
 
BBLG Bone Biologics Corporation
1.5200
-1.94%